§ Funding Round
Series C funding round for Escient Pharmaceuticals raising $120M in November 2022
Series C funding round for Escient Pharmaceuticals raising $120M in November 2022
| Investor | Firm Type | Partner |
|---|---|---|
| Organization | — | |
Access Biotechnology | — | — |
| Organization | — | |
| Angel | carol gallagher | |
| Angel | robert garland | |
Nextech Invest | — | — |
| Organization | — | |
| Organization | — | |
| Organization | — | |
| Organization | — | |
AbingworthLEAD | Organization | — |
| Organization | — | |
| Organization | — | |
Cowen Healthcare Investments | — | — |
| Organization | — | |
neaLEAD | Organization | — |
PFM Health Sciences | — | — |
| Organization | — | |
| Organization | — |
This company has completed 3 funding rounds. Current round is highlighted.
Total Raised
$238M
Top Valuation
-
Escient Pharmaceuticals raised $120M in a Series C round.
The round was announced on 11/01/22.
The round was led by Abingworth, forge life science partners, nea.
